There's so many long-standing stories that we've been tracking for many years that are coming to a hedge just this week and it's trying trying to do this so let's jump to this story here speaking of really making people's making their own decision. This is the story of Bear, Bear Pharmaceutical Company. They're from Germany in 2016. They acquired Monsanto for over 6060 billion.

This was the largest ever by a German buyer,

largest ever investment acquisition by a German buyer ever.

And of course at that point, investors on board this was the greatest thing this huge

juggernaut Bear and Monsanto obviously acquiring Monsanto because of their flagship product

roundup the Glaxo great product good idea bear genius right their flagship product round up, their glass. Great product.

Good idea, Bear.

Genius.

And one of the things Bear didn't tell its investors

is there is a global groundswell,

basically yearly marches against Monsanto.

People do not like this company.

There's some major issues with our products,

but that was swept under the rug.

Well, there's lawsuits and that's where Brent Wisner comes in.

This is attorney Brent Wisner, he was on our show.

He won the first lawsuit, helped Duane Johnson, he was the plaintiff, non-Hodgians lymphoma from glyphosate

use, he was spraying it and public parks and so this just these these lawsuits just keep coming and coming and coming for these cancer cases and things just really race to ahead at the end of October here.

So I'm going to run through three quick Reuters headlines just to give you the space of this.

October 20th, Bear must pay 1.25 million in Roundup cancer trial jury fines. Seven days later, Bear ordered to pay

175 million in latest Roundup cancer trial. And then another one, just a couple days later,

October 31st bear

...